Is Osseus profitable in 2026?

No. Osseus is a 2-person, pre-revenue Y Combinator S26 company as of July 25, 2026, with no disclosed revenue, customer counts, or named enterprise logos found in any independent source.

Could AI replace Osseus?

Possibly. Osseus's core pitch, surfacing past research and experts, overlaps directly with Anthropic's Claude for Life Sciences and OpenAI enterprise connectors. Anthropic added native Memory to Claude Team and Enterprise plans on 2025-09-12, a feature that threatens Osseus's thin RAG-over-connectors approach.

Osseus is a private company backed by Y Combinator as part of its Summer 2026 (S26) batch. YC's standard investment is $500k for a set equity stake; no subsequent funding round or named lead investor was found as of 2026-07-27.

Who is Osseus's biggest competitor?

Osseus names Glean, Benchling (750 employees) and Anthropic's Claude for Life Sciences as adjacent players. None are structurally barred from copying its permissioned R&D memory layer, and the brief flags an 18 to 24 month window before differentiation compresses.

Has Osseus raised money beyond Y Combinator?

No subsequent funding round, valuation, or ownership change beyond YC's initial $500k investment was found in available sources as of 2026-07-27, indicating the company remains at pre-seed/seed stage post-batch.

Does Osseus have real paying customers?

Unconfirmed. As of 2026-07-27 no revenue figures, customer counts, or named enterprise logos appear in third-party sources; the company's own demo site shows mock-ups (e.g., a hypothetical VP contact 'Ravi Anand') rather than verified traction.

YC Summer 2026 · United States

Osseus

Two-person startup building a permissioned AI memory layer across R&D tools.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Q3-Q4 2026 · Every call on the record Checkpoint: First design-partner cohort onboarding and 90 day retention test

The call

Osseus has a real integration idea but no proof yet that its memory layer outlasts the window before bigger players copy it.

Osseus is a two-person startup building software that lets scientists and engineers keep shared memories across different expensive tools they already use, like design software and simulation programs. Right now it is not hard to copy because the technology is straightforward: the real advantage is being first and moving fast. Big companies like Glean (which already sells AI assistants to offices) can add research features, and the giants like OpenAI could build memory tools straight into their own products, making Osseus unnecessary. The one thing that could change everything is whether the first customers actually stick with Osseus long enough to build up years of saved decisions and experiments, making it too costly to switch to a bigger competitor.

Why

AI pressure: Anthropic and OpenAI enterprise connectors with native org-memory features. Frontier labs are adding enterprise memory and connectors, which could absorb Osseus's thin RAG-over-connectors layer. Could AI do the core job? Yes, likely.

Bigger players: Glean. Glean's horizontal work-AI already mirrors permissions and could add R&D connectors like Teamcenter or Benchling quickly. Could a giant copy it? Yes, easily.

What protects it. Deep, permission-mirroring integrations into specialist tools like Ansys and Teamcenter, if the accumulated memory proves hard to switch away from.

What would change this call

Whether Osseus's first design partners still use it after 90 days. Tests if org memory actually compounds and creates switching cost.
Glean announces an R&D-specific vertical or Teamcenter/Ansys connectors. Would show the horizontal incumbent closing Osseus's integration gap.
Anthropic or OpenAI ships native org-memory features in enterprise tiers. Would show frontier labs absorbing Osseus's core value proposition.

Key numbers

2 employees listed in YC directory (2026-07-25)
$500k standard YC batch investment (2026)
0 confirmed paying customers or revenue found (2026-07-27)

Named risks

Pre-revenue, 2-person team with zero confirmed customers as of 2026-07-27. Severity: high
Core value prop overlaps with Anthropic Claude for Life Sciences and OpenAI enterprise connectors already shipping. Severity: high
Claimed connector depth and accumulated org memory are unbuilt plans, not shipped assets. Severity: medium
No incumbent (Glean, Benchling, Siemens) is structurally barred from replicating the product. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Glean	contesting	Horizontal enterprise AI not structurally barred from adding R&D connectors within 18-24 month window (2026)
Benchling	contesting	750-employee incumbent with AI Scientist feature; could widen scope into Osseus's territory (2026-07-25)
Anthropic (Claude for Life Sciences / Memory)	losing to	Added native Memory to Claude Team/Enterprise plans 2025-09-12, overlapping Osseus's core value prop
Siemens Teamcenter/Ansys	contesting	Ecosystem partners Osseus depends on, with mild disincentive to stay open to third-party connectors

Questions people ask

Is Osseus profitable in 2026?: No. Osseus is a 2-person, pre-revenue Y Combinator S26 company as of July 25, 2026, with no disclosed revenue, customer counts, or named enterprise logos found in any independent source.
Could AI replace Osseus?: Possibly. Osseus's core pitch, surfacing past research and experts, overlaps directly with Anthropic's Claude for Life Sciences and OpenAI enterprise connectors. Anthropic added native Memory to Claude Team and Enterprise plans on 2025-09-12, a feature that threatens Osseus's thin RAG-over-connectors approach.
Who owns Osseus?: Osseus is a private company backed by Y Combinator as part of its Summer 2026 (S26) batch. YC's standard investment is $500k for a set equity stake; no subsequent funding round or named lead investor was found as of 2026-07-27.
Who is Osseus's biggest competitor?: Osseus names Glean, Benchling (750 employees) and Anthropic's Claude for Life Sciences as adjacent players. None are structurally barred from copying its permissioned R&D memory layer, and the brief flags an 18 to 24 month window before differentiation compresses.
Has Osseus raised money beyond Y Combinator?: No subsequent funding round, valuation, or ownership change beyond YC's initial $500k investment was found in available sources as of 2026-07-27, indicating the company remains at pre-seed/seed stage post-batch.
Does Osseus have real paying customers?: Unconfirmed. As of 2026-07-27 no revenue figures, customer counts, or named enterprise logos appear in third-party sources; the company's own demo site shows mock-ups (e.g., a hypothetical VP contact 'Ravi Anand') rather than verified traction.

Timeline

2026-07-27Evidence review finds no funding round, lawsuits, or M&A activity beyond YC's initial investment
2026-07-25YC directory lists Osseus under Enterprise Software, S26 batch, 2 employees
2026-07-17Earlier YC snapshot also shows Osseus at 2 employees, no headcount growth in one week
2025-09-12Anthropic adds native Memory to Claude for Team and Enterprise plans, a competing capability

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Cosmic Robotics Pango Atlas Discovery